Morinamide

{{Short description|Chemical compound}}

{{Drugbox

| Watchedfields = changed

| verifiedrevid = 444187979

| IUPAC_name = N-(morpholin-4-ylmethyl)pyrazine-2-carboxamide

| image = Morinamide.svg

| image_class = skin-invert-image

| tradename =

| Drugs.com = {{drugs.com|international|morinamide}}

| pregnancy_AU =

| pregnancy_US =

| pregnancy_category =

| legal_AU =

| legal_BR = A1

| legal_BR_comment = {{Cite web |author=Anvisa |author-link=Brazilian Health Regulatory Agency |date=2023-03-31 |title=RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial |trans-title=Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control|url=https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |url-status=live |archive-url=https://web.archive.org/web/20230803143925/https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992 |archive-date=2023-08-03 |access-date=2023-08-16 |publisher=Diário Oficial da União |language=pt-BR |publication-date=2023-04-04}}

| legal_CA =

| legal_UK =

| legal_US =

| legal_status =

| routes_of_administration =

| bioavailability =

| protein_bound =

| metabolism =

| elimination_half-life =

| excretion =

| CAS_number = 952-54-5

| ATC_prefix = J04

| ATC_suffix = AK04

| PubChem = 70374

| DrugBank_Ref = {{drugbankcite|correct|drugbank}}

| DrugBank =

| UNII_Ref = {{fdacite|correct|FDA}}

| UNII = 8CFL28PA3W

| KEGG_Ref = {{keggcite|correct|kegg}}

| KEGG = D07248

| ChemSpiderID = 63555

| C=10 | H=14 | N=4 | O=2

| smiles = C1COCCN1CNC(=O)C2=NC=CN=C2

| StdInChI = 1S/C10H14N4O2/c15-10(9-7-11-1-2-12-9)13-8-14-3-5-16-6-4-14/h1-2,7H,3-6,8H2,(H,13,15)

| StdInChIKey = GVTLAVKAVSKBKK-UHFFFAOYSA-N

}}

Morinamide (or morphazinamide, or morinamid) is a drug used in the treatment of tuberculosis.{{cite journal |vauthors=Bonanni G, Ciccariello M, Mancini P, Pace V, Sagliaschi G |title=Concomitant ceco-appendicular and urinary tuberculosis. Description of two rare cases: physiopathological and diagnostic remarks |journal=Riv Eur Sci Med Farmacol |volume=15 |issue=3–4 |pages=171–4 |year=1993 |pmid=7761665 }} It behaves as a prodrug for Pyrazinamide.